About
Carterra Bio develops high-throughput Surface Plasmon Resonance (SPR) platforms that enable rapid antibody screening and characterization for drug discovery and biopharmaceutical research.
Explore Carterra Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.